Edition:
United Kingdom

Onxeo SA (C4X.PA)

C4X.PA on Paris Stock Exchange

0.98EUR
18 Oct 2018
Change (% chg)

€0.00 (+0.31%)
Prev Close
€0.98
Open
€0.99
Day's High
€0.99
Day's Low
€0.98
Volume
33,905
Avg. Vol
149,341
52-wk High
€2.49
52-wk Low
€0.98

Chart for

About

Onxeo SA, formerly Bioalliance Pharma SA, is a France-based biopharmaceutical company. In July 2014, the Company, as the continuing entity, merged with Topotarget AS creating Onxeo, a company dedicated to orphan oncology diseases. Onxeo aims at holding a portfolio of advanced programs targeting severe pathologies with unmet... (more)
No analyst recommendations are available for .

Overall

Beta: 0.73
Market Cap(Mil.): €88.20
Shares Outstanding(Mil.): 50.69
Dividend: --
Yield (%): --

Financials

  C4X.PA Industry Sector
P/E (TTM): -- 30.95 33.73
EPS (TTM): -0.45 -- --
ROI: -20.47 14.77 14.31
ROE: -24.16 16.27 16.04

BRIEF-Onxeo Announces Start Of DRIIV Phase 1 Clinical Study Of AsiDNA

* ANNOUNCES START OF DRIIV, PHASE 1 CLINICAL STUDY OF ASIDNA IN ADVANCED SOLID TUMORS Source text for Eikon: Further company coverage: (Gdynia Newsroom)

24 Apr 2018

Earnings vs. Estimates